Literature DB >> 12651616

Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis.

Guangwen Cao1, Guang Yang, Terry L Timme, Takashi Saika, Luan D Truong, Takefumi Satoh, Alexei Goltsov, Sang Hee Park, Taoyan Men, Nobuyuki Kusaka, Weihua Tian, Chengzhen Ren, Hongyu Wang, Dov Kadmon, Wei Wen Cai, A Craig Chinault, Timothy B Boone, Allan Bradley, Timothy C Thompson.   

Abstract

Using LoxP/Cre technology, we generated a knockout mouse homozygous for a null mutation in exon 2 of Cav1. In male Cav1-/- animals, we observed a dramatic increase in the incidence of urinary calcium stone formation. In 5-month-old male mice, the incidence of early urinary calculi was 67% in Cav1-/- mice compared to 19% in Cav1+/+ animals. Frank stone formation was observed in 13% of Cav1-/- males but was not seen in Cav1+/+ mice. Urine calcium concentration was significantly higher in Cav1-/- male mice compared to Cav1+/+ mice. In Cav1-/- mice, distal convoluted tubule cells were completely devoid of Cav1 and the localization of plasma membrane calcium ATPase was disrupted. Functional studies confirmed that active calcium absorption was significantly reduced in Cav1-/- compared to Cav1+/+ male mice. These results demonstrate that disruption of the Cav1 gene promotes the progressive steps required for urinary calcium stone formation and establish a new mouse model for urinary stone disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12651616      PMCID: PMC1851223          DOI: 10.1016/S0002-9440(10)63920-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.

Authors:  D A Bushinsky; M D Grynpas; J R Asplin
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

Review 2.  Nephrolithiasis.

Authors:  S J Scheinman
Journal:  Semin Nephrol       Date:  1999-07       Impact factor: 5.299

Review 3.  Toward a comprehensive molecular model of active calcium reabsorption.

Authors:  J G Hoenderop; P H Willems; R J Bindels
Journal:  Am J Physiol Renal Physiol       Date:  2000-03

4.  Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer.

Authors:  S A Tahir; G Yang; S Ebara; T L Timme; T Satoh; L Li; A Goltsov; M Ittmann; J D Morrisett; T C Thompson
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

5.  ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.

Authors:  N Piwon; W Günther; M Schwake; M R Bösl; T J Jentsch
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

6.  Elevated caveolin-1 levels in African-American versus white-American prostate cancer.

Authors:  G Yang; J Addai; M Ittmann; T M Wheeler; T C Thompson
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

7.  Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker.

Authors:  G Yang; L D Truong; T M Wheeler; T C Thompson
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

8.  Cellular adaptation of the mouse cortical thick ascending limb of Henle's loop (CTAL) to dietary magnesium restriction: enhanced transepithelial Mg2+ and Ca2+ transport.

Authors:  M Wittner; S Jounier; G Deschênes; C de Rouffignac; A Di Stefano
Journal:  Pflugers Arch       Date:  2000-04       Impact factor: 3.657

9.  Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

Authors:  S S Wang; O Devuyst; P J Courtoy; X T Wang; H Wang; Y Wang; R V Thakker; S Guggino; W B Guggino
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

10.  Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis.

Authors:  O Tamai; N Oka; T Kikuchi; Y Koda; M Soejima; Y Wada; M Fujisawa; K Tamaki; H Kawachi; F Shimizu; H Kimura; T Imaizumi; S Okuda
Journal:  Kidney Int       Date:  2001-02       Impact factor: 10.612

View more
  38 in total

1.  Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings.

Authors:  Ettickan Boopathi; Cristiano Mendes Gomes; Robert Goldfarb; Mary John; Vittala Gopal Srinivasan; Jaber Alanzi; S Bruce Malkowicz; Hasmeena Kathuria; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

3.  Biomechanical properties and innervation of the female caveolin-1-deficient detrusor.

Authors:  Mardjaneh Karbalaei Sadegh; Mari Ekman; Catarina Rippe; Frank Sundler; Nils Wierup; Michiko Mori; Bengt Uvelius; Karl Swärd
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 4.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

5.  Caveolin-1: a new locus for human lipodystrophy.

Authors:  Abhimanyu Garg; Anil K Agarwal
Journal:  J Clin Endocrinol Metab       Date:  2008-04       Impact factor: 5.958

6.  Caveolin-1 Deficiency Inhibits the Basolateral K+ Channels in the Distal Convoluted Tubule and Impairs Renal K+ and Mg2+ Transport.

Authors:  Lijun Wang; Chengbiao Zhang; Xiaotong Su; Dao-Hong Lin; Wenhui Wang
Journal:  J Am Soc Nephrol       Date:  2015-04-06       Impact factor: 10.121

7.  Whole exome sequencing identifies de novo heterozygous CAV1 mutations associated with a novel neonatal onset lipodystrophy syndrome.

Authors:  Abhimanyu Garg; Martin Kircher; Miguel Del Campo; R Stephen Amato; Anil K Agarwal
Journal:  Am J Med Genet A       Date:  2015-04-21       Impact factor: 2.802

8.  NF-κB and GATA-Binding Factor 6 Repress Transcription of Caveolins in Bladder Smooth Muscle Hypertrophy.

Authors:  Chellappagounder Thangavel; Cristiano M Gomes; Stephen A Zderic; Elham Javed; Sankar Addya; Jagmohan Singh; Sreya Das; Ruth Birbe; Robert B Den; Satish Rattan; Deepak A Deshpande; Raymond B Penn; Samuel Chacko; Ettickan Boopathi
Journal:  Am J Pathol       Date:  2019-01-30       Impact factor: 4.307

Review 9.  Transcytosis at the blood-brain barrier.

Authors:  Swathi Ayloo; Chenghua Gu
Journal:  Curr Opin Neurobiol       Date:  2019-01-30       Impact factor: 6.627

10.  Caveolin-1 overexpression in benign and malignant salivary gland tumors.

Authors:  Zohreh Jaafari-Ashkavandi; Mohammad Javad Ashraf; Ali Dehghani Nazhvani; Zahra Azizi
Journal:  Tumour Biol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.